| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.066 | 0.4 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.4 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.061 | 0.4 |